UK Health

Health officials investigate penile hyaluronic acid injection risks in Olympic ski jumpers.

The International Ski and Snowboard Federation (FIS) has dismissed as a “wild rumour” allegations that male ski jumpers have been injecting their penises with hyaluronic acid to gain a competitive advantage, according to The Independent.

The claims, which first appeared in German media and have been dubbed ‘Penisgate’, suggested the procedure would enlarge the organ, allowing for a larger competition suit to provide more lift and enable longer jumps. The World Anti-Doping Agency has said it would examine the allegations.

Medical experts have warned that such injections pose significant health risks. Urological surgeon Dr. Eric Chung stated that poor technique or incorrect dosing could cause penile pain, disfigurement, deformity, infection, inflammation, sensory change and sexual dysfunction.

He added that, in rare instances, infection could spread and cause gangrene, resulting in the loss of the penis.

Documented Health Complications

Cases of severe harm from such procedures have been recorded. A 2021 Japanese study detailed a 65-year-old man who required a partial penectomy to remove necrotic tissue after receiving hyaluronic acid injections for enlargement.

Separately, Australian researchers reported a 31-year-old man with a history of penile filler injections developing septic shock and significant skin loss, requiring intensive care. Dr. Chung indicated such complications could relate to Fournier’s gangrene, a rare, life-threatening bacterial infection.

Regulatory and Safety Status of Hyaluronic Acid

While hyaluronic acid is naturally produced in the body and is commonly used in FDA-approved dermal fillers for the face and hands, its use for penile enhancement is not approved. Medical sources note that no injectable has been approved by the U.S. Food and Drug Administration for increasing penis size, making any such application an off-label use.

A key safety feature of approved hyaluronic acid fillers is that they can be dissolved if adverse effects occur, but this approval does not extend to use in the penis.

Maribel Lockwoode

Health & Environment Reporter
Maribel Lockwoode is a health and environment reporter based in York, UK. She writes about public health policy, environmental challenges, and wellbeing issues, with a focus on evidence-based reporting and long-term public impact. Her coverage aims to inform readers through balanced analysis and reliable data.
· NHS and healthcare system reporting, environmental legislation tracking, data-driven public health analysis
· NHS policy and waiting lists, mental health services, climate action, wildlife and biodiversity, renewable energy, water quality

Related Articles

Back to top button